Skip to content
In this tutorial, we build an end-to-end autonomous AI co-scientist workflow for next-generation EGFR inhibitor discovery, focusing on the C797S osimertinib-resistance mutation in non-small cell lung cancer. We start by resolving the biological target through ChEMBL and UniProt, then mine curated EGFR IC50 bioactivity records and convert them into a clean pIC50 modeling dataset. We use RDKit to st...